67
Participants
Start Date
March 20, 2018
Primary Completion Date
January 11, 2020
Study Completion Date
November 18, 2020
Natalizumab
As specified in the treatment arm.
Placebo
As specified in treatment arms.
Research Site, The Bronx
Research Site, Syracuse
Research Site, Rochester
Research Site, Philadelphia
Research Site, Washington D.C.
Research Site, Chevy Chase
Research Site, Bethesda
Research Site, Chapel Hill
Research Site, Durham
Research Site, Asheville
Research Site, Charleston
Research Site, Jacksonville
Research Site, Tallahassee
Research Site, Maitland
Research Site, Orlando
Research Site, Tampa
Research Site, Birmingham
Research Site, Akron
Research Site, Saginaw
Research Site, Chicago
Research Site, St Louis
Research Site, Dallas
Research Site, Phoenix
Research Site, Phoenix
Research Site, Santa Monica
Research Site, San Diego
Research Site, Honolulu
Research Site, Renton
Research Site, Boston
Research Site, Boston
Research Site, Camden
Lead Sponsor
Biogen
INDUSTRY